Literature DB >> 8910605

Thyrotropin via cyclic AMP induces insulin receptor expression and insulin Co-stimulation of growth and amplifies insulin and insulin-like growth factor signaling pathways in dog thyroid epithelial cells.

R Burikhanov1, K Coulonval, I Pirson, F Lamy, J E Dumont, P P Roger.   

Abstract

Despite the similarity of their receptors and signal transduction pathways, insulin is regarded as a regulator of glucose, protein, and lipid metabolism, whereas insulin-like growth factors (IGF-I and IGF-II) mainly act as mitogenic hormones. In the dog thyroid primary culture model, the triggering of DNA synthesis by thyrotropin (TSH) through cAMP, or by cAMP-independent factors including epidermal growth factor, hepatocyte growth factor and phorbol esters, requires insulin or IGFs as comitogenic factors. In the present study, in TSH-treated cells, IGF-I receptors and insulin receptors were paradoxically equivalent in their capacity to elicit the comitogenic pathway, which, however, was mediated only by IGF-I receptors in dog thyroid cells stimulated by cAMP-independent mitogens. Moreover, prior cell exposure to TSH or forskolin increased their responsiveness to insulin, IGF-I, and IGF-II, as seen on DNA synthesis and activation of a common insulin/IGF signaling pathway. To understand these observations, binding characteristics and expression of insulin and IGF-I receptors were examined. To analyze IGF-I receptor characteristics, the unexpected interference of a huge presence of IGF-binding proteins at the cell membrane was avoided using labeled Long R3 IGF-I instead of IGF-I. Strikingly, TSH, through cAMP, time-dependently induced insulin binding and insulin receptor mRNA and protein accumulation without any effect on IGF-I receptors. These findings constitute a first example of an induction of insulin receptor gene expression by a cAMP-mediated hormone. In dog thyroid cells, this allows low physiological insulin concentrations to act as a comitogenic factor and might explain in part the enhanced responsiveness to IGFs in response to TSH. This raises the possibility that TSH-insulin interactions may play a role in the regulation of thyroid growth and function in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910605     DOI: 10.1074/jbc.271.46.29400

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin.

Authors:  K Coulonval; F Vandeput; R C Stein; S C Kozma; F Lamy; J E Dumont
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

2.  Effect of the interaction of TSH and insulin on the stimulation of 2-deoxyglucose uptake in FRTL-5 cells.

Authors:  D Silberschmidt; L Krawiec; L V Bocanera; G J Juvenal; M A Pisarev
Journal:  J Endocrinol Invest       Date:  1999 Jul-Aug       Impact factor: 4.256

Review 3.  The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma.

Authors:  Roberto Vita; Antonio Ieni; Giovanni Tuccari; Salvatore Benvenga
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

4.  An assessment of the relationship between thyroid nodule characteristics, insulin resistance and arterial stiffness in euthyroid nodular goiter.

Authors:  Yasemin Aydoğan; Mustafa Altay; Oktay Ünsal; Veysel Kaplanoğlu; Yavuz Çağır; Canan Yıldız; Esin Beyan; Selma Uysal Ramadan
Journal:  Endocrine       Date:  2018-08-06       Impact factor: 3.633

5.  Conditional deletion of insulin receptor in thyrocytes does not affect thyroid structure and function.

Authors:  Sangmi Ock; Seok Hong Lee; Jihyun Ahn; Tae Jin Lee; Chung-Hyun Cho; E Dale Abel; Shioko Kimura; Jaetaek Kim
Journal:  Endocr J       Date:  2011-09-08       Impact factor: 2.349

6.  A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes.

Authors:  F Depoortere; A Van Keymeulen; J Lukas; S Costagliola; J Bartkova; J E Dumont; J Bartek; P P Roger; S Dremier
Journal:  J Cell Biol       Date:  1998-03-23       Impact factor: 10.539

7.  Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: A randomized placebo-controlled clinical trial.

Authors:  Mozhgan Karimifar; Ashraf Aminorroaya; Masoud Amini; Taghi Mirfendereski; Bijan Iraj; Awat Feizi; Atsa Norozi
Journal:  J Res Med Sci       Date:  2014-11       Impact factor: 1.852

8.  In vitro silencing of the insulin receptor attenuates cellular accumulation of fibronectin in renal mesangial cells.

Authors:  Naohiro Yano; Daisuke Suzuki; Masayuki Endoh; Weizhi Zhang; Yan Chun Xu; James F Padbury; Yi-Tang Tseng
Journal:  Cell Commun Signal       Date:  2012-10-12       Impact factor: 5.712

Review 9.  Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis.

Authors:  G C Hard
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

Review 10.  Insulin-Like Growth Factor Pathway and the Thyroid.

Authors:  Terry J Smith
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.